Science
How LymphDetectTM Works
LymphDetect leverages a tumor informed next generation sequencing approach to detect post-operative residual disease in lymphatic drain fluid.

Droplet leverages next-generation sequencing from Illumina and NVIDIA GPU’s and Parabricks technology to return results rapidly and efficiently.

Droplet’s novel approach
to earliest timepoint MRD
Proximity
Timing
Accuracy
Closest biofluid to tumor
Collection 24 hrs after surgery
Tumor informed bespoke assays accounting for germline mutations
Increased concentration of tumor DNA
Results available before adjuvant decisions
NGS used to detect mutations at necessary timepoint
Improved sensitivity to detect residual disease
Precision adjuvant therapy for superior outcomes
Lymphatic fluid contains 2X more tumor DNA and 65X more ctDNA than timepoint matched plasma
Proximity
Closest biofluid to tumor
Increased concentration of tumor DNA
Improved sensitivity to detect residual disease
Timing
Collection 24hrs after surgery
Results available before adjuvant decisions
Precision adjuvant therapy for superior outcomes
Accuracy
Tumor informed bespoke assays accounting for germline mutations
NGS used to detect mutations at necessary timepoint
Lymphatic fluid contains 2X more tumor DNA and 65X more ctDNA than timepoint matched plasma
